The agreement solidifies Unilabs’ position as an industry-leading diagnostics service provider and is a major milestone for Mobidiag in European market entry
Mobidiag’s CEO Tuomas Tenkanen was invited this morning to major Finnish television channel MTV3, along with expert Jaana Vuopio (Professor, University of Turku), to talk about the global threat of resistant super bacteria.
Tenkanen explained how Mobidiag’s Amplidiag® assays and Novodiag® instrument could be a cost-effective solution to help counter the unnecessary use of antibiotics and contribute to the fight against microbes.
Watch the replay on: http://www.mtvkatsomo.fi/?progId=613696
Mobidiag’s CEO Tuomas Tenkanen was invited this morning to major Finnish television channel MTV3, along with expert Jaana Vuopio (Professor, University of Turku), to talk about the global threat of resistant super bacteria.
Tenkanen explained how Mobidiag’s Amplidiag® assays and Novodiag® instrument could be a cost-effective solution to help counter the unnecessary use of antibiotics and contribute to the fight against microbes.
Watch the replay on: http://www.mtvkatsomo.fi/?progId=613696
Mikrobiologiskt vårmöte och Infektionsveckan is the largest national meeting place for microbiology and infection and is held for the 2nd year in a row as a jointly organized between the microbiologic organizations (FKM, RFM, SFM), the organization of the infectious disease doctors and the infectious disease nurses.
Expanding at a colossal rate, in 2017 MEDLAB Middle East will launch as a standalone event. Housing over 700 exhibitors alongside nine dedicated conference tracks, solely dedicated to showcasing the latest technology and knowledge in the IVD and medical laboratory market.
The 1st to the 3rd of June, the Norwegian Bioingeniørfagliginstitutt hosts Bioingeniørkongressen 2016, the national congress for biomedical scientist and others that work within medical laboratories. The Venue is the Oslo Congresscenter.
Come meet us at the 33rd Annual Meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases held in Rovaniemi, Finland on 15.-18.9.2016!
Come meet us at booth #74 at the 26th European Congress of Clinical Microbiology and Infectious Diseases (9-12.4.2016, Amsterdam, Netherlands)
During the event, learn more about Amplidiag® assays during our lunch seminar
April, Monday 11th at 12:30pm (Amtrium 2)
Did you miss this lunch seminar?
Do not worry, you can now access the summary of our Amplidiag® presentation here.
Come meet us at the “35e Réunion interdisciplinaire de chimiothérapie anti-infectieuse” exhibition organized in le Palais des Congrès de Paris, France, on 14.-15.12.2015!
The agreement solidifies Unilabs’ position as an industry-leading diagnostics service provider and is a major milestone for Mobidiag in European market entry
Come meet us at the Kaakonkulma exhibition in Kotka!
Test is first-to-market, non-invasive IVD assay for reliable detection of both Helicobacter pylori and clarithromycin resistance from stool sample
Mobidiag Ltd, a Finnish molecular diagnostics company specialized in the development of innovative diagnostics solutions for infectious diseases, today announced the CE-IVD marking of Amplidiag™ H. pylori+ClariR.
Meet us at Infektiopäivät on 25th and 26th August 2015. More information at a later date!
Welcome to visit us at Mobidiag’s booth #221 at ECCMID!
Novodiag™ and Amplidiag™ Easy platforms to serve both low- and high-throughput customer needs with emphasis on accessibility and affordability
Mobidiag Ltd, a Finnish molecular diagnostics company specializing in the development of innovative diagnostics solutions for infectious diseases, today announced the first public presentation of two new diagnostic platforms – Novodiag and Amplidiag Easy – at ECCMID 2015 in Copenhagen on April 25-28.
Mobidiag Announces CE Mark Approval for Clostridium Difficile Infection and Hypervirulent 027 Ribotype
Test offers high sensitivity and specificity for pathogenic C. difficile and highly accurate differentiation of the hypervirulence-associated 027 ribotype
Mobidiag Announces CE-IVD Marking of Amplidiag™ Bacterial GE for Fast and Accurate PCR-Based Diagnostics of Gastroenteritis
Test optimizes screening of gastroenteritis-causing bacteria directly from stool samples
MERGER ANNOUNCEMENT
Helsinki, Finland and Paris, France – April 12, 2013
Mobidiag, Genewave, and Amplidiag announce merger to create a leading innovator in molecular diagnostics
The new Mobidiag to offer integrated, high-multiplex diagnostic tests for infectious diseases